Tag: Deviation

Analyzing Deviations across Batches During Technology Transfer: A Case Study on FDA Observations Technology transfer in pharmaceutical manufacturing is a critical process that can introduce risks, including the potential for…

Case Study: Assessing the Regulatory Impact of Unplanned Hold Time Extensions During Inspection Preparation In pharmaceutical manufacturing, the unexpected occurrence of unplanned hold time during inspection preparation can significantly compromise…

Breaking Down FDA Observations: Equipment Used Without Release in Manufacturing In pharmaceutical manufacturing, ensuring compliance with Good Manufacturing Practice (GMP) is critical to maintaining product quality and regulatory approval. This…

Case Study: Impact of Unapproved Process Change during Routine Manufacturing In a recent incident at a pharmaceutical manufacturing facility, a process change was implemented without the necessary Quality Assurance (QA)…

Assessment of a Manufacturing Process Change Implemented Without QA Approval In the highly regulated pharmaceutical industry, adherence to established protocols is paramount. This case study discusses a significant deviation where…

Case Study: Addressing a Deviation Closed Without Effectiveness Check During Changeover Understanding and resolving manufacturing deviations is critical in pharmaceutical production. This case study focuses on a specific instance where…

“`html Root Cause Analysis in Pharmaceutical Manufacturing: Addressing the Execution of a Batch with Expired SOP In a recent real-world scenario, a pharmaceutical manufacturer discovered that a batch of product…

Analysis of an Unapproved Change in Process Parameters During a Commercial Campaign In the landscape of pharmaceutical manufacturing, maintaining compliance with Good Manufacturing Practices (GMP) is crucial to ensure product…

Breakdown of FDA Inspection Observations Following an Unapproved Process Parameter Change During Commercial Campaign In the highly regulated environment of pharmaceutical manufacturing, adhering to established process parameters is critical. A…

Exploring Unapproved Process Parameter Changes During Inspection Readiness and CAPA Outcomes A large pharmaceutical manufacturing facility recently faced a significant challenge leading to substantial operational disruptions and heightened scrutiny during…

Analysis of an Unapproved Process Parameter Change in Inspection Readiness In a recent scenario at a biopharmaceutical manufacturing facility, an unapproved change to a process parameter was discovered during preparations…

Investigation into Unplanned Hold Time Extensions During Inspection Preparations In the highly regulated pharmaceutical industry, any deviation from established protocols can lead to significant regulatory scrutiny. This case study details…